Usefulness of Lipid Apheresis in the Treatment of Familial Hypercholesterolemia

Table 4

Cardiac events.

	Before apheresis ()	After apheresis ()	Total
Event count
Stent/PTCA	16	8	24
CABG	5	1	6
MI	13	0	13
Total cardiac events	34	9	43
Patient count
Stent/PTCA	7 (63.6%)	4 (36.4%)	7 (63.6%)
CABG	4 (36.4%)	1 (9.1%)	4 (36.4%)
MI	5 (45.5%)	0 (0.0%)	5 (45.5%)
Total patient count  with events	8 (72.7%)	5 (45.5%)	8 (72.7%)
			-value
Cardiac event rate	0.23 (95% CI)	0.10 (95% CI)	0.064